Emcure Pharmaceuticals reported a 20.4% year-on-year revenue growth for Q2FY25, reaching ₹2,002 crore, driven by a 25% increase in international sales, particularly in Canada. Domestic sales grew by 15.4% to ₹933 crore, supported by a Sanofi distribution agreement. Profit After Tax surged 38.2% to ₹202 crore, with EBITDA margins improving to 20.8%.
Alembic Pharmaceuticals reported a 12.3% profit increase to Rs 153.41 crore for Q2 FY25, with revenue rising 3.3% to Rs 1,647.98 crore. Emcure Pharmaceuticals saw a 38.2% profit surge to Rs 201.55 crore, while Indian Hotels Co Ltd's profit skyrocketed 232.2% to Rs 554.58 crore, driven by strong demand and operational growth.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
